Bonk, Inc.: Business Overview, Financials & Competitive Analysis
Bonk, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Early-stage wellness company with explosive growth trajectory but unproven long-term sustainability in a competitive OTC supplement market. Bonk demonstrates strong revenue growth momentum and operational profitability achievement in early 2026, but remains a micro-cap company with limited market presence and reliance on a niche wellness category. Insider buying by leadership.
What is Bonk, Inc.'s industry? Bonk, Inc. (bonkdat.com) operates in Micronutrients. AskCyborg classifies Bonk, Inc. under Micronutrients in its company registry.
Bonk, Inc. provides over-the-counter products and consumer products in the United States, including Safety Shot Beverage, hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. The company...
Cyborg Score thesis
Early-stage wellness company with explosive growth trajectory but unproven long-term sustainability in a competitive OTC...
Read the full analyst-debate transcript →Get the Latest Bonk, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBonk, Inc. Overview
Pro stress-test →Bonk, Inc. provides over-the-counter products and consumer products in the United States, including Safety Shot Beverage, hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. The company sells its products through direct customers, distributors, retailers, and e-commerce websites.
Strategic Profile
Pro stress-test →The company was formerly known as Safety Shot, Inc. and changed its name to Bonk, Inc. in October 2025. The rebranding and product diversification reflect a strategic shift from a single-product beverage focus toward a broader wellness and dietary supplement portfolio. Revenues surged over 10,000% to $4.3M in Q1 2026 and the company achieved operational profitability.
Competitive Landscape
Pro stress-test →Bonk operates in the fragmented OTC wellness and dietary supplement market, competing against larger established consumer health companies and newer direct-to-consumer wellness brands. The company's proprietary Sure Shot formulation targeting alcohol metabolism provides differentiation, but faces competition from both traditional supplement manufacturers and emerging wellness beverage startups with greater scale and distribution reach.
Industry Context
Bonk, Inc. operates in Micronutrients.
Key facts
Founded: 2018 · Headquarters: Jupiter, Florida, US · Revenue: Estimated $4.3M for Q1 2026; full-year 2026 data pending · Market cap: Approximately $300M or less (micro-cap category)